Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Gastrointest Oncol ; 13(4): 1753-1760, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-36092331

RESUMO

Background: The recurrence of polyps after endoscopic treatment is a difficult problem and there may be an association between blood lipid levels and colorectal polyps, but this is controversial and the aim of this study is to explore the risk factors for colorectal polyp recurrence. Methods: A total of 357 patients who underwent intestinal polypectomy from January 1, 2019 to June 1, 2020 in Sichuan Provincial People's Hospital were included in this retrospective study to analyze the potential association between blood indices and recurrence risk. Polyp recurrence was defined as the detection of 1 or more polyps at any time after polypectomy, regardless of site. Follow-up was performed through the electronic medical record system. Patients' age, gender, tobacco and alcohol liking, duration of follow-up, body mass index (BMI), polyp size, number, type of pathology, and lipid profiles (triglycerides, cholesterol, apolipoprotein B, and apolipoprotein A) were collected. Results: Triglycerides (1.54±0.95 vs. 1.25±1.01, P=0.036) and apolipoprotein B (0.87±0.26 vs. 0.79±0.16 mL, P=0.001) were significantly different in both the recurrence and non-recurrence groups. Binary logistic regression identified 3 independent risk factors for recurrence: triglycerides [odds ratio (OR): 1.763, 95% confidence interval (CI): 1.003 to 3.098, P=0.049], apolipoprotein B (OR: 5.438, 95% CI: 1.411 to 20.961, P=0.014), and the number of polyps (OR: 2.540, 95% CI: 1.649 to 3.911, P<0.001). Conclusions: High levels of triglycerides, apolipoprotein B, and the number of colorectal polyps are risk factors for colorectal polyp recurrence after endoscopic resection. Therefore, for patients at high risk of polyp recurrence, we recommend aggressive control of triglyceride and apolipoprotein B levels.

2.
Materials (Basel) ; 10(2)2017 Feb 06.
Artigo em Inglês | MEDLINE | ID: mdl-28772493

RESUMO

Olivine-type LiMnPO4/C nanorods were successfully synthesized in a chloride/ethylene glycol-based deep eutectic solvent (DES) at 130 °C for 4 h under atmospheric pressure. As-synthesized samples were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), Raman spectroscopy, Fourier transform infrared spectroscopy (FTIR) and electrochemical tests. The prepared LiMnPO4/C nanorods were coated with a thin carbon layer (approximately 3 nm thick) on the surface and had a length of 100-150 nm and a diameter of 40-55 nm. The prepared rod-like LiMnPO4/C delivered a discharge capacity of 128 mAh·g-1 with a capacity retention ratio of approximately 93% after 100 cycles at 1 C. Even at 5 C, it still had a discharge capacity of 106 mAh·g-1, thus exhibiting good rate performance and cycle stability. These results demonstrate that the chloride/ethylene glycol-based deep eutectic solvents (DES) can act as a new crystal-face inhibitor to adjust the oriented growth and morphology of LiMnPO4. Furthermore, deep eutectic solvents provide a new approach in which to control the size and morphology of the particles, which has a wide application in the synthesis of electrode materials with special morphology.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA